$0.4300
-0.11-19.66%
最終更新: Oct 16, 7:59 PM
$0.4300
-0.11-19.66%
Benzinga
Benzinga
Benzinga
土曜日, 10 17
Benzinga
© 2026 Benzinga | All Rights Reserved
Estrella Immunopharma (ESLA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.12 | $-0.12 | — |
| Actual | $-0.05 | $-0.05 | $-0.01 | $-0.13 |
| Surprise | +44.4% | +58.3% | +91.7% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.08 | $-0.07 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.05 | $-0.09 | 44.4 % |
| Q1 | May 18, 2026 | $-0.05 | $-0.12 | 58.3 % |
| Q4 | Mar 18, 2026 | $-0.01 | $-0.12 | 91.7 % |
| Q2 | Aug 12, 2025 | $-0.15 | $-0.11 | -36.4 % |